Company profile for Evaxion Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can harness its powers through novel immunotherapies. Our scalable AI-immunology core technology enables broad applicability across diseases with immunological components. With deep insights into the biological processes of the immune system, we bridge technology, engineering expertise...
We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can harness its powers through novel immunotherapies. Our scalable AI-immunology core technology enables broad applicability across diseases with immunological components. With deep insights into the biological processes of the immune system, we bridge technology, engineering expertise and drug development know-how to bring novel immunotherapies to patients.We are an AI-immunologyTM platform company decoding the human immune system to discover

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Dr. Neergaards Vej 5F, Hørsholm, Capital Region 2970
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/20/3191863/0/en/Evaxion-announces-positive-data-for-lead-antigens-in-cytomegalovirus-CMV-vaccine-program-EVX-V1.html

GLOBENEWSWIRE
20 Nov 2025
Evaxion Announce 2026 Financial Calendar
Evaxion Announce 2026 Financial Calendar

12 Nov 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/11/12/3186142/0/en/Evaxion-announce-2026-financial-calendar.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/07/3184002/0/en/Evaxion-presents-new-immune-data-from-phase-2-trial-with-AI-designed-personalized-cancer-vaccine-EVX-01.html

GLOBENEWSWIRE
07 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179338/0/en/Evaxion-expands-R-D-pipeline-with-new-AI-designed-precision-cancer-vaccine-candidate.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/31/3178358/0/en/Correction-Evaxion-to-announce-business-update-and-third-quarter-2025-financial-results-on-November-6-2025.html

GLOBENEWSWIRE
31 Oct 2025

https://www.globenewswire.com/news-release/2025/10/30/3177291/0/en/Evaxion-raises-7-2-million-extending-cash-runway-to-second-half-of-2027.html

GLOBENEWSWIRE
30 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty